Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You found it, you tell us ?? or do you want someone here to transcribe it for you while you go do something else ??
Stock price would be at least half way to the agreed amount... leaks would be on both sides. When have you seen a buyout with headline that reads ABC buys XYZ for a 3000% premium.. never... 200% premium, that is normal.
Urban Legend. Perhaps was valid in old days, they just group chat now. Never here on ihub. Yeah, nope, they would not sit on a park bench, talking about golf and alcohol.
How about 988 for shorts ??
mani, time is linear, so yes, you are not wrong. Longs will come and go, Shorts will come and go, on to speculate about the next stock.
Anyone 'holding' data, info or an article for a certain awareness day to get maximum attention is disingenuous to those that die and suffer.
There will be a nothingburger for NWBO/DCVAX on July 20th... I hope no one falls for a poorly organized set up.
I am just quoting the company's words, thus, my opinion from those actual words.
Ex. To be properly be informed, what is the current valuation of Advent Bio?
Crash.. they are posters, just like anyone else. Submit TOS if they did wrong.
Everyone should get their little internet fingers going and go to nwbio.com. find the last two press releases....near the end, section called "about Northwest Biotherapeutics" read the whole parapraph... 'released top line data" is said, by the company, in both recent PR's. Fact.
Is there more...oh hell yes there will be.
LPOW is a smart cookie, so, I am sure there is a valid, legal reason for a delay.
And maybe last, if Merckophiles are right...but I highly, highly doubt it.
Their actions seem to me, for a while now, to be 'go it alone'.
How long does a share count/audit take on average?
GB, momentul2play is making that connection about Duffy meaning a deal, that now maybe snubbed. I think Duffy is at Regeneron now anyway, so, maybe was on the outs for a while at Merck.
This is why Duffy was at NWBO...
ZERO mention of merger...
Dr. Duffy commented “My years at Merck, from inception of the Keytruda programs, have been exciting and invaluable. As I look forward now to the next wave of advances in immune therapies for cancer, I am excited about the potential of NW Bio’s DCVax technologies to deliver new breakthroughs for patients. I hope to build on my experience in immuno-oncology and my network of relationships in the field to help NW Bio achieve this potential.”
Linda Powers, CEO of NW Bio, noted that “Dr. Duffy’s experience with immune therapies for cancer and one of the most successful product development programs in the field will be an invaluable addition to our team. We at NW Bio could not be more excited about Dr. Duffy’s choice to join us and help realize the broad potential of DCVax.”
https://nwbio.com/nw-bio-expands-senior-management-team-with-dr-kevin-duffy-as-vice-president-medical-affairs-external-collaborations/
So, hiring a subject matter expert means a merger is in the works?
Who's saying a Merck and NWBO deal was in the works?
Pattyloco, Reality is, DCVAX is not yet approved for commercial sales. Yet, the market cap is $733,000,000... that is pretty ok by me. Now, when they gain ability to commercially sell DCVAX, then sales estimates can begin. Until any approval, it's a early-stage biotech.
A journal article will NOT make it approved and sellable.
A PR will NOT make it approved and sellable.
Breadcrumbs will NOT make it approved and sellable.
A RS will NOT make it approved and sellable.
An offering will NOT make it approved and sellable.
Watch out for the windmill, knocks the ball every time.
Only Court participants will be short sellers...
The company did not put survival data in public domain, longs did that.
I would argue the basic survival data is not TLD, since it's both a fine line and a vague one at the same time.
The company, despite many accusations, is operating morally and to high standards. I do not believe they are trying to be a bad business partner to Streeter-vile.
Vator, Who's saying there's a TLD lawsuit ??
No more Breadbrumbs...upgraded to Checkmarks.
Whoa Whoa.. who says "birthing person"... it's now "connected cellular matter expulsion entity"
OK, I just made that up. But, it does sound more inclusionary. LOL.
Advent is in Canada for a week... almost forgot about this event.
https://twitter.com/EveryTrade/status/1545041117959180289
I wonder if Krysten Powers will be there ?? That would be very interesting...
I assume you must think/know a 250K+ order is sitting in the wings? An 15-18% Babe Ruth call out is pretty bold.
DCVAX still standing when failures keep adding up for others.
Black Swan Ranch https://excelsiorproject.com/place/black-swan-ranch/
Nice Gold Digger wordsmithing. Really, really N.I.C.E. one.
3 to 4 years ordeal now over. Hit the bottom recently. I’m a lucky bastard. I am all good now. My Payback to society is to focus on my powers to make promising therapeutics like DC-VAX cross the finish line. Cancer really fucks you up at time scale that are longer than expected pic.twitter.com/QwW8rfdWSC
— Michael Bigger (@biggercapital) July 5, 2022
I liked my Duncedencel.
I remember googling 'dcvax' and for a while, it came up Washington D.C. Covid vaccination info... NWBO lawyers probably squashed that usage of a trademarked vaccine name.
Duncedencel maybe ??
Are Byeong Hoon Kang and Heung Kyu Lee related to NWBO ??
The silence is intentional. Given that every PR has been used against them, why would NWBO issue any more? I would not.
Those demanding PR's or criticizing for not having issues one, well, they might be wanting to sell on the news.
The company has learned some harsh lessons and they are simply putting their noses to the grindstone and working towards the goal of commercial availability, not a journal IMHO.
I agree with Al Musella that Journal articles are not normally attached as a file in drug applications.
I think JC was simply meaning an unskilled intern is smarter than NWBO management, that's the meat of the burger.
Jerry, my money is on a CFO/CEO who is sharp as a tack caught it.
The accounting firm missed it the first time. Since LPOW has been globe trotting for multiple high level meetings lately, I am sure she finally got a breath on a flight and found the error.
Parallel does not mean SAME finish time.
Think of it as multi-lane highway, with different exits. Parallel driving, but destination and timing may be different. This is the only was I have seen the "in parallel" statement from company.